A carregar...
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies
Fluoropyrimidines form the mainstay in treatment of gastrointestinal malignancies. For decades 5-fluorouracil (5FU), was the major fluoropyrimidine. Currently it is usually given in a combination with leucovorin and oxaliplatin, i.e. FOLFOX, or irinotecan, i.e. FOLFIRI, or all three, i.e. FOLFIRINOX...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2015-11-01
|
| Colecção: | Therapeutic Advances in Medical Oncology |
| Acesso em linha: | https://doi.org/10.1177/1758834015603313 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|